XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Income Statement - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Revenue $ 59,380 $ 57,786 [1] $ 54,304 [1]
Cost of sales (27,396) (26,305) [1] (23,097) [1]
Gross profit 31,984 31,481 [1] 31,207 [1]
Distribution expenses (6,277) (6,389) [1] (5,889) [1]
Sales and marketing expenses (7,158) (6,752) [1] (7,292) [1]
Administrative expenses (4,738) (4,414) [1] (4,394) [1]
Other operating income/(expenses) 778 841 [1] 805 [1]
Exceptional costs above profit from operations (624) (251) [1] (614) [1]
Profit from operations 13,966 14,517 [1] 13,824 [1]
Finance cost (6,133) (5,814) [1] (6,040) [1]
Finance income 1,031 1,665 [1] 431 [1]
Net finance income/(cost) (5,102) (4,148) [1] (5,609) [1]
Share of result of associates 295 299 [1] 248 [1]
Exceptional share of results of associates (35) (1,143) [1] 0 [1]
Profit before tax 9,124 9,524 [1] 8,463 [1]
Income tax expense (2,234) (1,928) [1] (2,350) [1]
Profit of the period 6,891 7,597 6,114
Profit of the period attributable to:      
Equity holders of AB InBev 5,341 5,969 [1] 4,670 [1]
Non-controlling interest $ 1,550 $ 1,628 [1] $ 1,444 [1]
Basic earnings per share $ 2.65 $ 2.97 [1] $ 2.33 [1]
Diluted earnings per share $ 2.6 $ 2.91 [1] $ 2.28 [1]
[1] As from 1 January 2023, mark-to-market gains/(losses) on derivatives related to the hedging of the share-based payment programs are reported in the exceptional net finance income/(cost). The 2021 and 2022 presentation were amended to conform to the 2023 presentation.